Pharmafile Logo

Pharmerit rebrands to OPEN Health

May 20, 2021 |  

OPEN Health is moving to one brand to create a world-class integrated services model

Pharmerit, a global leader in Health Economics and Outcomes Research (HEOR) and Market Access, has undergone an extensive rebranding to fully integrate with OPEN Health. Since its inception in 2011, OPEN Health has expanded its expertise and global reach through mergers and organic growth to be at the forefront of the healthcare industry. It has brought together global experts from HEOR, Market Access, and medical communications, with digital at the heart of its services. OPEN Health provides unrivalled global healthcare specialist expertise to apply innovative approaches in research and communications with the purpose of improving patient outcomes and wellbeing.

“We are one of the few global agencies that can serve clients across the full product lifecycle,” commented Rob Barker, CEO of OPEN Health. “We are proud to partner with 38 of the top 40 biopharmaceutical and medical device companies, serving clients from Medical Affairs, HEOR, Market Access, and Commercial teams.”

As of April 2021, OPEN Health has moved to one brand to create a world-class integrated services model. Together, we are a global team of 750+ experts across the United States, Europe, United Kingdom, and Asia.

“I am excited to say that we have retained the very best of Pharmerit, which has supported so many clients for over 20 years. We are now uniting equivalent life science research and communications talents from around the world under the OPEN Health brand, which has a strong heritage. We will continue on our journey to deliver on our evidence and access promise with a new, dynamic, and fully integrated team of experts,” added Jeff Anderson, CEO of OPEN Health Evidence & Access.

Speaking of Pharmerit’s clients, the former co-founder of Pharmerit and current Chair of OPEN Health Evidence & Access, Marc Botteman, commented, “I am proud to say that our clients will find a vastly broadened set of capabilities under the OPEN Health brand, including the expansion of value and HEOR communication and writing, the addition of patient engagement capabilities to our patient-centered outcomes expertise, the inclusion of primary data collection capabilities, and extensive access to UK and European databases. This will allow us to combine our novel data analytics and machine learning expertise with deep commercial market access expertise across Europe.”

Over the past 12 months, OPEN Health has cemented its status as a leader in HEOR and medical communications. It has experienced 20% YTY growth, tallying 1400 customers in 90+ countries. This growth reflects the increasing need for HEOR to inform healthcare decisions and to engage with the healthcare community in innovative and personalized ways.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

NORD Rare Diseases Breakthrough Summit

Gavin Jones, Director of Rare Disease, provides his thoughts on last week’s NORD Breakthrough Summit and a collective need to reduce inequalities in rare disease

A day in the life of Becca McConnell a Senior Account Executive

We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health.

Responding to dynamic shifts in value communications

OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.

OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020

We are delighted to have won another Bronze Award at the PM Society Digital Awards 2020in the Healthcare Charities & Patient Associations Category for Alexander Devine Children's Hospice Service. READ MORE ABOUT OUR...

OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020

We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for  Excellence in Innovation: Immunology Training Summit.READ MORE ABOUT OUR WINNING PROJECT WITH WITH JANSSEN BELOW:The Immunology...

OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020

We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for Effectiveness: Market Access.READ MORE ABOUT OUR WINNING PROJECT “VAGUS NERVE STIMULATION - ADDRESSING INEQUALITY...

Meet OPEN Health and Pharmerit Experts at the World Pharma Pricing Market Access and Evidence Congress 2020

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:ROUNDTABLE: Wednesday, September 23,...

Reflections of a Fireside Chat from the World Orphan Drug Congress 2020

Hear from Trish Shepherd COO, Patient & Brand Communications, OPEN Health

OPEN Health has been awarded a Bronze Medal by EcoVadis

We are delighted to announce that OPEN Health has been awarded a Bronze Medal by EcoVadis for its very first Corporate Social Responsibility assessment in recognition of its commitment to Corporate Social...